JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Aclaris Therapeutics to Present at Upcoming Investor Conferences in June
-
Konzum and Mercator Tap Revionics Price and Promotion Optimization to Sharpen Competitive Focus, Scale for Continuing Growth
-
Aimmune Therapeutics to Present at Upcoming June Investor Conferences
-
NOVADAQ to Participate in June Investor Conferences
-
Retrophin to Present at Upcoming Investor Conferences
-
Insys Therapeutics, Inc. to Present at Two Upcoming Conferences in June
-
Twilio Files Registration Statement for Proposed Initial Public Offering
-
Minerva Neurosciences' (NERV) Price Target Raised to $17 at JMP Securities
-
Twilio (TWLO) Files for $100M IPO
-
BioCryst to Present at Two Upcoming Investor Conferences
-
JMP Securities Upgrades NICE Systems Ltd (NICE) to Market Outperform
-
Spring Bank Pharmaceuticals to Present at Upcoming Investor Conferences
-
Hersha Hospitality Trust Prices Public Offering of 6.50% Series D Preferred Shares
-
Editas Medicine to Present at Upcoming June Investor Conferences
-
Love's Travel Stops & Country Stores Taps Revionics' Unmatched Pricing and Promotions Solutions to Stay in Step with its Customers
-
Celtaxsys to Present at Jefferies Healthcare and JMP Securities Life Sciences Conferences
-
Intrexon to Present at Upcoming Investor and Industry Conferences
-
JMP Group Announces Addition of Joseph Osha to Equity Research Department
-
Concert Pharmaceuticals to Present at Several Upcoming Investor Conferences
-
Syndax Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Business Update Following IPO
-
Editas Medicine Announces First Quarter 2016 Results and Update
-
JMP Securities Downgrades Textura Corp (TXTR) to Market Perform
-
JMP Group Announces Addition of Don More to Investment Banking Division
-
Revionics Launches Global Retail Workshop Series Tailored to Empower Retailers
-
Revionics Announces Agreement with BJ's Wholesale Club
-
Green Dot Files Investor Presentation
-
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2016
-
Proteon Therapeutics Announces First Quarter 2016 Financial Results
-
JMP Securities Downgrades Cvent (CVT) to Market Perform
-
JMP Securities Upgrades Walker & Dunlop (WD) to Market Outperform
-
Egalet to Present at Upcoming Investor Conferences this Spring
-
United Online Agrees to be Acquired by B. Riley for $11 per Share
-
Flex Pharma Reports First Quarter 2016 Financial Results
-
Notable Analyst Rating Changes 5/3: (MEP) (RSG) (AXTI) Upgraded; (CYH) (UTX) (SRPT) Downgraded
-
JMP Securities Starts Intrexon (XON) at Market Outperform
-
JMP Securities Downgrades Cash America International (CSH) to Market Perform
-
JMP Securities Downgrades Enanta Pharmaceuticals (ENTA) to Market Perform
-
Revionics, EKN Research & MGM Resorts to Join Panel Discussion on Advanced Pricing Strategy
-
RiskIQ Selected as One of JMP Securities Fast 50 Hottest Privately Held Security Companies
-
JMP Securities Downgrades CYS Investments (CYS) to Market Perform
-
JMP Securities Starts Endo International plc (ENDP) at Market Outperform
-
JMP Group Declares Second Quarter 2016 Monthly Distributions and Increases Share Repurchase Authorization
-
JMP Group Reports First Quarter 2016 Financial Results
-
Yahoo results edge past estimates in good sign for sale of business
-
United Online Completes Sale of MyPoints
-
JMP Group to Report First Quarter Financial Results on April 19, 2016
-
Cvent, Inc. (CVT) has potential for higher bid - JMP Securities
-
Needham & Company Makes Key Appointments in Institutional Equities
-
JMP Securities Downgrades Carbylan Therapeutics (CBYL) to Market Perform
-
Intrexon (XON) Enters ECCs with Two Harvest Intrexon Enterprise Fund-Backed Startups

